Related Experiment Video

Updated: Aug 9, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Current developments in adenovirus-based cancer gene therapy

Daniel T Rein1, M Breidenbach, David T Curiel

  • 1University of Düsseldorf Medical Center, Department of Obstetrics and Gynecology, Düsseldorf, Germany.

Future Oncology (London, England)
|March 25, 2006
PubMed

Insights

Adenovirus (Ad)-based cancer gene therapy shows promise for resistant cancers. New strategies improve tumor targeting and infection, overcoming limitations of early Ad therapies for better efficacy.

Area of Science:

  • Oncolytic virology
  • Cancer gene therapy
  • Molecular virology

Background:

  • Adenovirus (Ad)-based cancer gene therapy offers a novel approach for treating drug-resistant cancers.
  • Early nonreplicative Ad vectors showed limited efficacy due to low infectivity, particularly with Ad serotype 5 (Ad5) linked to coxsackie-Ad receptor (CAR) expression variability.
  • Conditionally replicating Ads (CRAds) were developed to enhance tumor-specific replication and oncolysis.

Purpose of the Study:

  • To review recent advancements in Ad-based cancer gene therapy.
  • To highlight strategies for overcoming CAR-dependent infectivity limitations.
  • To discuss novel engineering techniques for improved tumor targeting and restricted transgene expression.

Main Methods:

  • Development of conditionally replicating Ads (CRAds) for tumor-specific replication.
  • Engineering of Ad capsids to enhance tumor targeting.
  • Application of molecular strategies for CAR-independent Ad infection.
  • Development of targeting techniques to restrict transgene expression to cancer cells.

Main Results:

  • CRAds enable tumor-specific replication, oncolysis, and progeny virus release.
  • Molecular strategies are being developed to create CAR-independent oncolytic Ads.
  • Novel Ad capsid engineering improves tumor targeting efficiency.
  • Targeting techniques aim to restrict transgene expression specifically within cancer cells.

Conclusions:

  • Recent developments focus on engineering Ad vectors for enhanced tumor targeting and overcoming CAR-dependent infectivity.
  • Molecular strategies and capsid modifications are crucial for improving the efficacy of Ad-based cancer gene therapy.
  • Future Ad-based therapies aim for greater specificity and effectiveness against resistant cancers.

More Related Videos

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on: July 14, 2023

An Efficient Method for Adenovirus Production10:06

An Efficient Method for Adenovirus Production

Published on: June 10, 2021

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...